MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

Search

Novavax Inc

Gesloten

SectorGezondheidszorg

5.97 -0.67

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

5.66

Max

6.22

Belangrijke statistieken

By Trading Economics

Inkomsten

40M

-81M

Verkoop

3.8M

88M

EPS

-0.52

Winstmarge

-91.755

Werknemers

952

EBITDA

52M

-53M

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+146.66% upside

Dividenden

By Dow Jones

Volgende Winsten

9 mei 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-140M

1.1B

Vorige openingsprijs

6.64

Vorige sluitingsprijs

5.97

Nieuwssentiment

By Acuity

93%

7%

372 / 386 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Strong Bearish Evidence

Novavax Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

2 apr 2025, 17:06 UTC

Belangrijke Marktbewegers

Novavax Falls But Then Recovers After WSJ Report on Vaccine's FDA Status

31 mrt 2025, 14:19 UTC

Belangrijke Marktbewegers

Vaccine Stocks Fall After Ousting of FDA's Vaccine Head

4 feb 2025, 18:52 UTC

Belangrijke Marktbewegers

Psychedelic Drug Stocks Up, Vaccine Shares Down After Senate Committee Advances RFK Jr.

11 nov 2024, 14:05 UTC

Belangrijke Marktbewegers

Novavax to Move Forward With Covid-19, Influenza Vaccine After FDA Lifts Clinical Hold

16 okt 2024, 12:59 UTC

Belangrijke Marktbewegers

Novavax Says FDA Puts Clinical Hold on Covid-19, Flu Vaccines; Shares Drop

13 mei 2024, 18:14 UTC

Belangrijke Marktbewegers

Novavax Shares Pop Another 50% Following Sanofi Deal

10 mei 2024, 10:59 UTC

Belangrijke Marktbewegers

Novavax Shares Surge on $1.4 Billion Vaccine Licensing Deal with Sanofi

30 dec 2024, 23:02 UTC

Acquisities, Fusies, Overnames

Novavax Completes Previously Announced $200M Sale of Czech Republic Manufacturing Site to Novo Nordisk

4 dec 2024, 07:09 UTC

Acquisities, Fusies, Overnames

Novavax: Agreement to Close by Dec 30 >NVAX

4 dec 2024, 07:08 UTC

Acquisities, Fusies, Overnames

Novavax: Sale Aligns With Plan to Become More Lean Organization, Drive Value From Pipeline Assets & Tech Platform >NVAX

4 dec 2024, 07:07 UTC

Acquisities, Fusies, Overnames

Novavax: Deal to Also Reduce Annual Operating Costs by About $80M >NVAX

4 dec 2024, 07:06 UTC

Acquisities, Fusies, Overnames

Novavax to Get $190M Cash Payment in 2024, Additional $10M in 2025 >NVAX

4 dec 2024, 07:06 UTC

Acquisities, Fusies, Overnames

Novavax: Agreement Provides Company With Significant, Non-Dilutive Capital >NVAX

4 dec 2024, 07:04 UTC

Acquisities, Fusies, Overnames

Novavax Announces Sale of Czech Republic Manufacturing Site to Novo Nordisk for $200M

15 nov 2024, 13:34 UTC

Top Nieuws

Heard on the Street: RFK Jr. Is Spooking Obesity Investors Too -- WSJ

15 nov 2024, 11:14 UTC

Marktinformatie

U.S. Vaccine Stocks Fall After Trump Picks Vaccine Skeptic RFK Jr as Health Department Head-- Market Talk

16 okt 2024, 15:22 UTC

Winsten

These Stocks Are Moving the Most Today: ASML, Nvidia, Morgan Stanley, United Airlines, DJT, Novavax, J.B. Hunt, Cisco, and More -- Barrons.com

10 mei 2024, 20:11 UTC

Winsten

These Stocks Moved the Most Today: Novavax, Akamai, Sweetgreen, Taiwan Semi, Moderna, Gen Digital, JFrog, SoundHound, and More -- Barrons.com

10 mei 2024, 14:49 UTC

Winsten
Populaire aandelen

Stocks to Watch Friday: TSMC, Novavax, Nvidia -- WSJ

10 mei 2024, 10:47 UTC

Acquisities, Fusies, Overnames

Novavax Gets $1.4 Billion Deal With Sanofi. The Stock Jumps. -- Barrons.com

Peer Vergelijking

Prijswijziging

Novavax Inc Prognose

Koersdoel

By TipRanks

146.66% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 14.75 USD  146.66%

Hoogste 19 USD

Laagste 9 USD

Gebaseerd op 4 Wall Street-analisten die 12-maands prijsdoelen bieden voor Novavax Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

4 ratings

2

Buy

2

Hold

0

Sell

Technische score

By Trading Central

N/A / 7.011Steun & Weerstand

Korte Termijn

Strong Bearish Evidence

Gemiddeld Termijn

Weak Bearish Evidence

Lange Termijn

Bearish Evidence

Sentiment

By Acuity

372 / 386 Rangschikking in Gezondheidszorg

Nieuwssentiment

Zeer Sterk Bearish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Boven gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Novavax Inc

Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. It focuses on urgent health challenges, which is evaluating vaccines for COVID-19, influenza, and COVID-19 influenza combination. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It is also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.